High yield goes low yield with Fresenius
Europe’s high yield bond market broke into new territory this week as Fresenius, the German healthcare company that is one of its most prized issuers, priced a €500m 7.5 year bond at a coupon of just 2.875% — a level many investment grade companies would envy.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts